Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy.

Moratti E, Kashanpour H, Lombardelli T, Maisto M.

Clin Drug Investig. 2010;30 Suppl 1:3-11. doi: 10.2165/11536020-000000000-00000.

PMID:
20450240
2.

Evidence against a direct role played by transfusion-transmitted virus infection in causing hepatic or hematologic manifestations.

Toniutto P, Fabris C, Falleti E, Lombardelli T, Gasparini V, Barillari G, Biffoni F, Pirisi M.

Blood. 1999 Apr 1;93(7):2426-7. No abstract available.

PMID:
10215353
3.

IgM antibody response to the hepatitis C virus core protein in intravenous drug users.

Toniutto P, Falleti E, Gasparini V, Fabris C, Tisminetzky SG, Lombardelli T, Pacco P, Satta A, Pirisi M.

Diagn Microbiol Infect Dis. 1999 Feb;33(2):69-73.

PMID:
10091028
4.

Factors associated with serum HCV RNA positivity in anti-HCV antibody positive intravenous drug users.

Pirisi M, Toniutto P, Fabris C, Lombardelli T, Falleti E, Tisminetzky SG, Baralle F, Bartoli E.

J Clin Epidemiol. 1998 May;51(5):423-7.

PMID:
9619970
5.

Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions.

Toniutto P, Pirisi M, Tisminetzky SG, Fabris C, Chinellato E, Gerotto M, Falleti E, Ferroni P, Lombardelli T, Bartoli E, Baralle F.

J Clin Microbiol. 1996 Oct;34(10):2382-5.

Supplemental Content

Loading ...
Support Center